Undruggable, Drug Design, Proteins, Drug Discovery, AI.
concentrate on the most common cases of undruggability instead. We continue to work with the classical small molecules workflow (although the molecules could be not so small in this case). We prioritize the ease and low cost of synthesis of our drug candidates despite the “weird” nature of their